Abstract
Herpes zoster infection is a common clinical problem in elderly people. Three of the consequences of such infection are acute rash, post-herpetic neuralgia, and, for those with trigeminal infection, ocular complications. Post-herpetic neuralgia is a severe, prolonged, debilitating complication with no known effective treatment. Acyclovir treats acute rash,*RF 1-4* but its role in preventing post-herpetic neuralgia and ocular complications remains controversial. These complications can be severe and sight threatening and can require prolonged treatment. Topical acyclovir has been shown to be beneficial when given prophylactically and in established cases.5 We examined whether high oral doses of acyclovir (800 mg five times a day for seven days) have a beneficial effect on post-herpetic neuralgia and reduce ocular involvement in the long term. Of the …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
More From: BMJ
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.